Clinical and pathological features of breast cancer patients eligible for adjuvant abemaciclib. Tarantino P, Jin Q, Mittendorf EA, King TA, et al. Ann Oncol 2022 Apr 28. pii: S0923-7534(22)00754.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tarantino P, Jin Q, Mittendorf EA, King TA, et al. Clinical and pathological features of breast cancer patients eligible for adjuvant abemaciclib. Ann Oncol 2022 Apr 28. pii: S0923-7534(22)00754.
PMID: 35525374